KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Intangibles: 2020-2024

Historic Change in Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 3 years, with Sep 2024 value amounting to $129,000.

  • Aurinia Pharmaceuticals' Change in Intangibles rose 360.71% to $129,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $253,000, marking a year-over-year increase of 8.12%. This contributed to the annual value of $16,000 for FY2019, which is N/A change from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Change in Intangibles of $129,000 as of Q3 2024, which was up 53.57% from $84,000 recorded in Q2 2024.
  • Aurinia Pharmaceuticals' 5-year Change in Intangibles high stood at $162,000 for Q1 2023, and its period low was -$83,000 during Q4 2020.
  • Its 2-year average for Change in Intangibles is $77,500, with a median of $67,000 in 2023.
  • Within the past 5 years, the most significant YoY rise in Aurinia Pharmaceuticals' Change in Intangibles was 360.71% (2024), while the steepest drop was 92.59% (2024).
  • Aurinia Pharmaceuticals' Change in Intangibles (Quarterly) stood at -$83,000 in 2020, then soared by 92.77% to -$6,000 in 2021, then reached $28,000 in 2023, then surged by 360.71% to $129,000 in 2024.
  • Its Change in Intangibles stands at $129,000 for Q3 2024, versus $84,000 for Q2 2024 and $12,000 for Q1 2024.